Osteosarcoma (OS) differentially expressed genes (DEGs) have been predicted using the
data portal of the Therapeutically Applicable Research to Generate Effective Treatments …

Osteosarcoma (OS), also known as bone cancer, is a threat to the lives of millions of
adolescents worldwide. Although dedicated efforts have been invested in reducing the …

Background: In the past decade, accumulated evidence has suggested that genetic variation
is related to the pathogenesis of osteosarcoma. Although there are a large number of …

Materials sized 1–100 nm are the nanotechnology's field of interest. Because of the unique
properties such as the ability to penetrate biological barriers and a high surface to volume …

Cancer stem cells (CSCs) play an important role in drug resistance of tumor and are
responsible for high recurrence rates. Agents that can suppress the proliferation and …

Recent studies show that lncRNAs involve in the initiation and progression of various
cancers including osteosarcoma (OS). IncRNA Xist has been verified as an oncogene in …

Background Discovering how to regulate mitochondrial function to reduce cancer growth
holds great potential for future cancer therapy development. Here we explore the effects of …

Telomerase is crucial for the maintenance of stem/progenitor cells in adult tissues and is
detected in most malignant cancers, including osteosarcoma. However, the relationship …

Pediatric sarcomas are relatively rare malignancies individually. As a group they are
typically approached with combination chemotherapies in addition to local control …

Osteosarcoma (OSA) is malignant bone tumor, occurring in children and adults,
characterized by poor prognosis. Despite advances in chemotherapy and surgical …